Search by Drug Name or NDC

    NDC 78206-0148-01 Ontruzant Details

    Ontruzant

    Ontruzant is a INTRAVENOUS KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Organon LLC. The primary component is .

    Product Information

    NDC 78206-0148
    Product ID 78206-148_ad98aa3b-8438-40df-9a42-f034962edec5
    Associated GPIs 21170070342140
    GCN Sequence Number 080929
    GCN Sequence Number Description trastuzumab-dttb VIAL 420 MG INTRAVEN
    HIC3 V1W
    HIC3 Description ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY
    GCN 47917
    HICL Sequence Number 045571
    HICL Sequence Number Description TRASTUZUMAB-DTTB
    Brand/Generic Brand
    Proprietary Name Ontruzant
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ontruzant
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route INTRAVENOUS
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Organon LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761100
    Listing Certified Through 2024-12-31

    Package

    NDC 78206-0148-01 (78206014801)

    NDC Package Code 78206-148-01
    Billing NDC 78206014801
    Package 1 KIT in 1 CARTON (78206-148-01) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, SOLUTION in 1 VIAL
    Marketing Start Date 2021-06-01
    NDC Exclude Flag N
    Pricing Information N/A